ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Krystn Hammond joins Grant Thornton as CFO Advisory principal

15-year valuation and transaction veteran tapped to help clients across the life sciences industry

Grant Thornton, one of America’s largest brands for audit, assurance, tax, and advisory services, today announced that Krystn Hammond has joined the firm as a CFO Advisory principal within the Advisory Services practice.

With more than 15 years of experience, Hammond has advised pharmaceutical and life sciences clients on transactions and tax restructurings, including acquisitions, divestitures, spin-offs and intellectual property migrations. Her experience spans across industry subsectors, such as big pharma, biotech, medical devices and diagnostics, generics, specialty, animal health, consumer and services.

As a member of Grant Thornton’s Valuation and Modeling team, Hammond will focus on assisting life sciences clients with comprehensive valuation solutions that center on measuring value while helping organizations make better, more informed decisions.

“From advising on transactions to providing solutions across all life sciences subsectors, Krystn brings more than a decade of knowledge and skill to Grant Thornton’s CFO Advisory practice,” said Paul Melville, national managing principal of CFO Advisory at Grant Thornton Advisors LLC. “Her extensive experience helping organizations make strategic and thoughtful decisions will provide immense value for our firm and the clients we serve.”

Zara Muradali, national Life Sciences leader at Grant Thornton Advisors LLC, echoed Melville’s sentiment on the value Hammond’s experience will bring to Grant Thornton’s clients.

“The life sciences industry is constantly evolving, and our clients deserve quality-driven solutions that provide value to their businesses,” said Muradali. “Krystn's wealth of life sciences knowledge will help strengthen our industry offerings and provide our clients with tailored services that meet their unique needs.”

Prior to joining Grant Thornton, Hammond worked as a healthcare investment banker focused on strategic mergers and acquisitions at Stifel, via its acquisition of Torreya Capital, where she advised on transactions across generics, specialty pharma, complex formulations and infectious diseases. She also served as a director in PwC's Deals practice, where she focused on life sciences and led the firm's middle-market clients and opportunities initiative for the sector in the New York metro region.

“I’m grateful to be part of a firm that sets exemplary standards in everything from client service to company culture,” said Hammond about her new role at Grant Thornton. “I look forward to working with a team of dynamic valuation professionals to help our life sciences clients make well-informed strategic decisions to add value to both patients and shareholders.”

Based in New York, Hammond has served on the Junior Council of the American Ballet Theatre and as audit committee chair and treasurer of an international ballet scholarship competition. She is also a member of the Apollo Circle of the Metropolitan Museum of Art. Hammond received a bachelor’s degree in finance and master’s degree in accounting from the A.B. Freeman School of Business at Tulane University. She is a Chartered Financial Analyst (CFA) charterholder and a certified public accountant in New York.

To learn more about Grant Thornton’s CFO advisory services offerings, visit: https://www.grantthornton.com/services/advisory-services/cfo-advisory.

About Grant Thornton

Grant Thornton” is the brand for two professional-services entities: Grant Thornton LLP, a licensed, certified public accounting (CPA) firm that provides audit and assurance services ― and Grant Thornton Advisors LLC (not a licensed CPA firm), which exclusively provides non-attest offerings, including tax and advisory services. With revenues of $2.4 billion for the fiscal year that ended July 31, 2023, and dozens of offices nationwide, Grant Thornton represents a community of almost 10,000 problem solvers, relationship builders, and industry specialists who know that how we serve matters as much as what we do.

Grant Thornton LLP, Grant Thornton Advisors LLC and their respective subsidiaries operate as an alternative practice structure (APS). The APS conforms with applicable laws, regulations and professional standards, including those from the American Institute of Certified Public Accountants.

Grant Thornton LLP and Grant Thornton Advisors LLC serve as the U.S. member firms of the Grant Thornton International Ltd (GTIL) network. GTIL and its member firms are not a worldwide partnership and all member firms are separate legal entities. Member firms deliver all services; GTIL does not provide services to clients.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+1.37 (0.56%)
AAPL  268.47
-1.30 (-0.48%)
AMD  233.54
-4.16 (-1.75%)
BAC  53.20
-0.09 (-0.17%)
GOOG  279.70
-5.64 (-1.98%)
META  621.71
+2.77 (0.45%)
MSFT  496.82
-0.28 (-0.06%)
NVDA  188.15
+0.07 (0.04%)
ORCL  239.26
-4.54 (-1.86%)
TSLA  429.52
-16.39 (-3.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.